Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin
Condition(s):HealthyLast Updated:July 28, 2014Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:July 28, 2014Completed
Condition(s):Small Cell Lung CarcinomaLast Updated:April 6, 2022Active, not recruiting
Condition(s):Portal Hypertension.; Liver CirrhosisLast Updated:January 25, 2011Unknown status
Condition(s):Sleep DisordersLast Updated:July 21, 2017Completed
Condition(s):Subarachnoid HemorrhageLast Updated:February 4, 2015Completed
Condition(s):Smoking CessationLast Updated:April 13, 2020Completed
Condition(s):HypercholesterolemiaLast Updated:May 24, 2012Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:July 2, 2009Completed
Condition(s):Cystic Fibrosis; Systemic InflammationLast Updated:January 30, 2014Withdrawn
Condition(s):Invasive Breast Carcinoma; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7Last Updated:August 1, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.